Menu
Search
|

Menu

Close
X

Viveve Medical Inc VIVE.OQ (NASDAQ Stock Exchange Capital Market)

4.46 USD
-0.08 (-1.76%)
As of Feb 17
chart
Previous Close 4.54
Open 4.56
Volume 315,472
3m Avg Volume 54,794
Today’s High 4.61
Today’s Low 4.46
52 Week High 11.16
52 Week Low 3.30
Shares Outstanding (mil) 19.41
Market Capitalization (mil) 108.86
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.71 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY17
10
FY16
7
FY15
1
EPS (USD)
FY17
-1.608
FY16
-2.210
FY15
-3.037
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
10.45
5.77
Price to Book (MRQ)
vs sector
6.81
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
115.00
16.52
LT Debt to Equity (MRQ)
vs sector
115.00
12.22
Return on Investment (TTM)
vs sector
-103.95
14.43
Return on Equity (TTM)
vs sector
-217.66
16.13

EXECUTIVE LEADERSHIP

James Atkinson
Chief Business Officer and President, Since 2015
Salary: $329,600.00
Bonus: $132,000.00
Patricia Scheller
Chief Executive Officer, Director, Since 2014
Salary: $380,000.00
Bonus: $190,000.00
Scott Durbin
Chief Financial Officer, Since 2013
Salary: $323,440.00
Bonus: $130,000.00
Lori Bush
Independent Director, Since 2017
Salary: --
Bonus: --
Daniel Janney
Lead Independent Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

150 Commercial St
SUNNYVALE   CA   94086-5201

Phone: +1408.5301900

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.

SPONSORED STORIES